{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T10:40:23Z","timestamp":1778236823557,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:00:00Z","timestamp":1720569600000},"content-version":"vor","delay-in-days":9,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100021726","name":"Direktorat Riset and Pengembangan, Universitas Indonesia","doi-asserted-by":"publisher","award":["2023"],"award-info":[{"award-number":["2023"]}],"id":[{"id":"10.13039\/501100021726","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.heliyon.2024.e34500","type":"journal-article","created":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T06:09:24Z","timestamp":1720678164000},"page":"e34500","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Determination of warfarin in volumetric absorptive microsampling by liquid chromatography-tandem mass spectrometry"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7217-7900","authenticated-orcid":false,"given":"Yahdiana","family":"Harahap","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Callista Andinie","family":"Mulyadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hary Sakti","family":"Muliawan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Habibah A.","family":"Wahab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e34500_bib1","first-page":"1","article-title":"Indications for anticoagulant and antiplatelet combined therapy","volume":"359","author":"Floyd","year":"2017","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34500_bib2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3329\/fmcj.v13i1.38018","article-title":"A review of warfarin dosing and monitoring","volume":"13","author":"Arif","year":"2018","journal-title":"Faridpur Med. Coll. J."},{"key":"10.1016\/j.heliyon.2024.e34500_bib3","series-title":"Goodman & Gilman's the Pharmacological Basis of Therapeutics","author":"Brunton","year":"2011"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e34500_bib4","first-page":"515","article-title":"Determination of plasma warfarin concentrations in Korean patients and its potential for clinical application","volume":"29","author":"Kwon","year":"2009","journal-title":"Korean Journal of Laboratory Medicine"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e34500_bib5","first-page":"1","article-title":"A chiral HPLC-MS\/MS method for simultaneous quantification of warfarin enantiomers and its major hydroxylation metabolites of CYP2C9 and CYP3A4 in human plasma","volume":"1","author":"Ju","year":"2014","journal-title":"Austin J. Anal. Pharm. Chem."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e34500_bib6","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1161\/01.CIR.0000063575.17904.4E","article-title":"American Heart Association\/American College of Cardiology foundation guide to warfarin therapy","volume":"107","author":"Hirsh","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.heliyon.2024.e34500_bib7","series-title":"WHO Expert Committee on Biological Standardization. Annex 6: Guidelines for Thromboplastins and Plasma Used to Control Oral Anticoagulant Therapy","year":"2013"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e34500_bib8","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jpba.2006.03.019","article-title":"Study on warfarin plasma concentration and its correlation with international normalized ratio","volume":"42","author":"Sun","year":"2006","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34500_bib9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jyp.2013.02.001","article-title":"Estimation of plasma levels of warfarin and 7-hydroxy warfarin by high performance liquid chromatography in patients receiving warfarin therapy","volume":"5","author":"Kumar","year":"2013","journal-title":"J. Young Pharm."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34500_bib10","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4103\/japtr.japtr_259_21","article-title":"Validation of warfarin enantiomer analysis method in plasma using high-performance liquid chromatography fluorescence detector","volume":"13","author":"Putriana","year":"2022","journal-title":"\\\"J. Adv. Pharm. Technol. Research\\\"\\\" (JAPTR)\\\""},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34500_bib11","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/bmc.1616","article-title":"Determination of free and total warfarin concentrations in plasma using UPLC MS\/MS and its application to a patient samples","volume":"26","author":"Radwan","year":"2012","journal-title":"Biomed. Chromatogr."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34500_bib12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.chroma.2012.11.046","article-title":"Development of a chiral micellar electrokinetic chromatography\u2013tandem mass spectrometry assay for simultaneous analysis of warfarin and hydroxywarfarin metabolites: application to the analysis of patients serum samples","volume":"1271","author":"Wang","year":"2013","journal-title":"J. Chromatogr. A"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e34500_bib13","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.4155\/bio-2019-0041","article-title":"Microsampling: considerations for its use in pharmaceutical drug discovery and development","volume":"11","author":"Spooner","year":"2019","journal-title":"Bioanalysis"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e34500_bib14","first-page":"104","article-title":"Screening for phenylketonuria","volume":"9","author":"Guthrie","year":"1969","journal-title":"Triangle"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e34500_bib15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.22159\/ijap.2019v11i2.30310","article-title":"Clinical application of dried blood spot for monitoring studies of tamoxifen, endoxifen, and 4-hydroxytamoxifen in breast cancer patient using liquid chromatography\u2013tandem mass spectrometry","volume":"11","author":"Harahap","year":"2019","journal-title":"Int. J. Appl. Pharm."},{"key":"10.1016\/j.heliyon.2024.e34500_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2023.123801","article-title":"Standardization and validation of a novel UPLC-MS\/MS method to quantify first line anti-tuberculosis drugs in plasma and dried blood spots","volume":"1228","author":"Herrera-P\u00e9rez","year":"2023","journal-title":"J. Chromatogr., B: Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.heliyon.2024.e34500_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115438","article-title":"Quantification of nine psychotropic drugs in postmortem dried blood spot samples by liquid chromatography\u2013tandem mass spectrometry for simple toxicological analysis","volume":"233","author":"Nishio","year":"2023","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.heliyon.2024.e34500_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2022.123131","article-title":"Determination of polymyxin B in dried blood spots using LC-MS\/MS for therapeutic drug monitoring","volume":"1192","author":"Huang","year":"2022","journal-title":"J. Chromatogr., B: Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.heliyon.2024.e34500_bib19","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jchromb.2015.06.014","article-title":"Analysis of metformin, sitagliptin and creatinine in human dried blood spots","volume":"997","author":"Scherf-Clavel","year":"2015","journal-title":"J. Chromatogr., B: Anal. Technol. Biomed. Life Sci."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e34500_bib20","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jfda.2019.06.001","article-title":"Simultaneous determination of cardiovascular drugs in dried blood spot by liquid chromatography-tandem mass spectrometry","volume":"27","author":"Kim","year":"2019","journal-title":"J. Food Drug Anal."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e34500_bib21","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/01.tp.0000250730.30715.63","article-title":"Dried blood spot measurement of tacrolimus is promising for patient monitoring","volume":"83","author":"Hoogtanders","year":"2007","journal-title":"Transplantation"},{"issue":"16","key":"10.1016\/j.heliyon.2024.e34500_bib22","doi-asserted-by":"crossref","first-page":"8489","DOI":"10.1021\/ac5022562","article-title":"Volumetric absorptive microsampling: a dried sample collection technique for quantitative bioanalysis","volume":"86","author":"Denniff","year":"2014","journal-title":"Anal. Chem."},{"key":"10.1016\/j.heliyon.2024.e34500_bib23","year":"2022","journal-title":"M10 Bioanalytical Method Validation and Study Sample Analysis: Guidance for Industry"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34500_bib24","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/13880209.2018.1478431","article-title":"Influence of andrographolide on the pharmacokinetics of warfarin in rats","volume":"56","author":"Zhang","year":"2018","journal-title":"Pharm. Biol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34500_bib25","doi-asserted-by":"crossref","first-page":"5808","DOI":"10.1038\/s41598-020-62573-z","article-title":"Quantification for non-targeted LC\/MS screening without standard substances","volume":"10","author":"Liigand","year":"2020","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e34500_bib26","doi-asserted-by":"crossref","first-page":"128","DOI":"10.25077\/jsfk.8.2.128-144.2021","article-title":"Review metode analisis warfarin dalam plasma dengan berbagai instrumen","volume":"8","author":"Sholihah","year":"2021","journal-title":"Jurnal Sains Farmasi & Klinis"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34500_bib27","article-title":"Influence of solvent composition and surface tension on the signal intensity of amino acids in electrospray ionization mass spectrometry","volume":"8","author":"Kageyama","year":"2019","journal-title":"Mass Spectrom."},{"key":"10.1016\/j.heliyon.2024.e34500_bib28","volume":"vol. 76","author":"Wu","year":"2004"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34500_bib29","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/jms.395","article-title":"Liquid chromatographic\/electrospray ionization tandem mass spectrometric study of the phenolic composition of cocoa (Theobroma cacao)","volume":"38","author":"S\u00e1nchez-Rabaneda","year":"2003","journal-title":"J. Mass Spectrom."},{"issue":"23","key":"10.1016\/j.heliyon.2024.e34500_bib30","doi-asserted-by":"crossref","first-page":"9033","DOI":"10.1021\/ac2023876","article-title":"Approach to evaluating dried blood spot sample stability during drying process and discovery of a treated card to maintain analyte stability by rapid on-card pH modification","volume":"83","author":"Liu","year":"2011","journal-title":"Anal. Chem."},{"key":"10.1016\/j.heliyon.2024.e34500_bib31","series-title":"Sample Preparation in LC-MS Bioanalysis","author":"Li","year":"2019"},{"key":"10.1016\/j.heliyon.2024.e34500_bib32","series-title":"Mass Spectrometry for the Clinical Laboratory","first-page":"37","article-title":"Sample preparation techniques for mass spectrometry in the clinical laboratory","author":"Stone","year":"2017"},{"key":"10.1016\/j.heliyon.2024.e34500_bib33","year":"2018","journal-title":"Bioanalytical Method Validation: Guidance for Industry"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e34500_bib34","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cca.2008.03.008","article-title":"Measurement of free concentrations of highly protein-bound warfarin in plasma by ultra performance liquid chromatography\u2013tandem mass spectrometry and its correlation with the international normalized ratio","volume":"393","author":"Huang","year":"2008","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.heliyon.2024.e34500_bib35","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.microc.2017.03.057","article-title":"Determination of warfarin and warfarin alcohols in dried blood spots by ultra-high performance liquid chromatography coupled to electrospray ionization-tandem mass spectrometry (UHPLC-ESI-MS\/MS)","volume":"136","author":"Ghimenti","year":"2018","journal-title":"Microchem. J."},{"key":"10.1016\/j.heliyon.2024.e34500_bib36","series-title":"Pharmacometric Models for Individualisation of Warfarin in Adults and Children","author":"Hamberg","year":"2013"},{"key":"10.1016\/j.heliyon.2024.e34500_bib37","article-title":"A novel, rapid and simple UHPLC-MS\/MS method for quantification of warfarin in dried blood spots","volume":"2022","author":"Qu","year":"2021","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.heliyon.2024.e34500_bib38","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.microc.2017.02.010","article-title":"Monitoring of warfarin therapy: preliminary results from a longitudinal pilot study","volume":"136","author":"Lomonaco","year":"2018","journal-title":"Microchem. J."},{"key":"10.1016\/j.heliyon.2024.e34500_bib39","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.chroma.2013.08.091","article-title":"Determination of total and unbound warfarin and warfarin alcohols in human plasma by high performance liquid chromatography with fluorescence detection","volume":"1314","author":"Lomonaco","year":"2013","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.heliyon.2024.e34500_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113102","article-title":"Opportunities and obstacles for microsampling techniques in bioanalysis: special focus on DBS and VAMS","volume":"182","author":"Londhe","year":"2020","journal-title":"J. Pharm. Biomed. Anal."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024105312?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024105312?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T13:35:43Z","timestamp":1773840943000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024105312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":40,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S2405844024105312"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34500","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determination of warfarin in volumetric absorptive microsampling by liquid chromatography-tandem mass spectrometry","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34500","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e34500"}}